Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG Eye Drops in Dry Eye Disease
NCT03992482Phase 2Completed
- Sponsor
- Akums Drugs
- Start
- May 2019
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in dry eye disease (DED), sponsored by Akums Drugs. Started May 2019; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03992482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03992482.